Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dietary interventions for phenylketonuria.

V J Poustie1, P Rutherford

  • 1Evidence Based Child Health Unit, Institute of Child Health, Royal Liverpool Children's Hospital NHS Trust, Alder Hey, Eaton Road, Liverpool, Merseyside, UK, L12 2AP. v.poustie@liv.ac.uk

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[High burden of disease in patients with ANCA-associated vasculitis : A claims data study in Germany].

Der Internist·2021
Same author

Working together to deliver stratified medicine research effectively.

British medical bulletin·2019
Same author

Low-dose aspirin for in vitro fertilisation.

The Cochrane database of systematic reviews·2007
Same author

Protein substitute for children and adults with phenylketonuria.

The Cochrane database of systematic reviews·2005
Same author

Reliability of calculating body mass index centile.

European journal of clinical nutrition·2005
Same author

Effect of introducing the Modified Early Warning score on clinical outcomes, cardio-pulmonary arrests and intensive care utilisation in acute medical admissions.

Anaesthesia·2003

Early phenylalanine-restricted diets for phenylketonuria (PKU) significantly lower blood phenylalanine levels and improve intelligence quotient. Continued dietary restriction is crucial for cognitive outcomes, though optimal levels and relaxation timing require further study.

Area of Science:

  • Metabolic Disorders
  • Genetics
  • Nutritional Science

Background:

  • Phenylketonuria (PKU) is an inherited metabolic disorder requiring early dietary phenylalanine restriction.
  • The restrictive nature of the diet presents challenges in adherence and long-term management.
  • Controversy exists regarding diet relaxation or discontinuation during adolescence versus lifelong adherence.

Purpose of the Study:

  • To evaluate the impact of early-initiated phenylalanine-restricted diets in PKU patients.
  • To assess adverse effects of diet relaxation/termination on cognitive function, growth, and quality of life.
  • To review evidence on optimal dietary management strategies for PKU.

Main Methods:

  • Searched the Cochrane Cystic Fibrosis and Genetic Disorders Trials Register and other relevant databases.

Related Experiment Videos

  • Included randomized or pseudorandomized controlled trials comparing phenylalanine-restricted diets with diet relaxation or termination.
  • Two independent reviewers assessed eligibility, quality, and extracted data.

    • Main Results:

    • Four studies with 251 patients were analyzed.
    • Significantly lower blood phenylalanine levels were observed in patients on restricted diets.
    • Higher intelligence quotients were noted in patients continuing the restricted diet, though based on one study.

    Conclusions:

    • Non-randomized studies suggest phenylalanine restriction improves cognitive and neuropsychological outcomes.
    • Ethical considerations preclude new randomized trials comparing no diet versus restriction from diagnosis.
    • Further randomized trials are needed to determine optimal phenylalanine levels and timing for diet relaxation.